TATAA Biocenter and Strand Life Sciences Announce Strategic Partnership
News Jun 24, 2015
TATAA Biocenter has partnered with Strand Life Sciences to advance the analysis of Next Generation Sequencing (NGS) data.
As part of the partnership, TATAA Biocenter will distribute and support Strand NGS, Strand’s premier analysis tool for NGS data, in Europe. TATAA is also going to use Strand NGS in its popular NGS training courses.
“We always seek collaboration with the best solution providers for our training courses and Strand Life Sciences are top of the class for NGS whole transcriptome profiling”, says Kristina Lind, coordinator of TATAA Biocenter’s hands-on training program. “Our customers request professional tools for the entire NGS workflow from sample preparation, quality control, library preparation, sequencing and data analysis.”, says Mikael Kubista, president of TATAA Biocenter, “With Strand NGS our customers obtain the most comprehensive and powerful tool for the analysis of Next Generation Sequencing data”.
“We have always welcomed collaborations for serving the customer better and for the greater good of science. Tataa Biocenter is an established player in Europe with a wide reach. European customers will now have access to one of the most comprehensive, commercially available, NGS analysis tools” says Scott Storrer, President of Strand Life Science.
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.